Biotech | May 09, 2022
SCG Cell Therapy announces HSA clinical trial approval of TCR-T cell therapy for liver cancer
SCG101 is an autologous T-cell receptor (TCR) T-cell therapy for liver cancer
SCG101 is an autologous T-cell receptor (TCR) T-cell therapy for liver cancer
Takeda and United Nations Global Compact Network of India (UNGCNI) join hands
The production suspension impacts commercial and clinical trial supply
There is a need for the Ministry of Health to put it on the priority list and address the issues, which are numerous
Upon closing, the Quakertown business will become an independent company called Microsize
The department will soon release a policy to catalyze research & development and innovation in the pharma- Medtech sector in India
RNAstorm and DNAstorm RNA/DNA extraction kits will be sold exclusively through the Biotium website and authorized distributors
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
The increase in PAT is driven by higher sales and lower marketing and depreciation charge vs the same period last year
While Pregabalin will be manufactured at the Aurangabad facility, Iloperidone will be manufactured at the Goa facility
Subscribe To Our Newsletter & Stay Updated
